MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

Search

Avalo Therapeutics

Suletud

4.77 -2.65

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

4.59

Max

4.98

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+451.1% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

11. aug 2025

Avalo Therapeutics Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

1. juuli 2025, 23:09 UTC

Tulu

Constellation Brands 1Q Profit, Sales Decline Amid Softer Consumer Demand -- Update

1. juuli 2025, 19:16 UTC

Omandamised, ülevõtmised, äriostud

Sabadell Seeks Shareholder Approval of Nearly $4 Billion Sale of U.K. Unit to Santander

1. juuli 2025, 23:47 UTC

Market Talk

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

1. juuli 2025, 23:41 UTC

Market Talk

Gold Steady, Underpinned by U.S. Fiscal-Deficit Concerns -- Market Talk

1. juuli 2025, 22:23 UTC

Omandamised, ülevõtmised, äriostud

James Hardie: Deal Represents Implied Value of $8.4 Billion

1. juuli 2025, 22:23 UTC

Omandamised, ülevõtmised, äriostud

James Hardie: Cash and Stock Deal Implies $54.18 Per AZEK Share

1. juuli 2025, 22:21 UTC

Omandamised, ülevõtmised, äriostud

James Hardie Completes Acquisition of AZEK

1. juuli 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

1. juuli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

1. juuli 2025, 20:24 UTC

Tulu

Constellation Brands Earnings Miss as Consumers Cool on Alcohol -- Barrons.com

1. juuli 2025, 19:55 UTC

Market Talk

Oil Futures Resume Cautious Rally -- Market Talk

1. juuli 2025, 19:27 UTC

Market Talk

U.S. Natural Gas Futures Lose More Ground -- Market Talk

1. juuli 2025, 19:12 UTC

Market Talk

Dollar Little Changed as Tax-And-Spending Bill Advances -- Market Talk

1. juuli 2025, 19:01 UTC

Omandamised, ülevõtmised, äriostud

Sabadell Seeks Shareholder Approval of Nearly $4B Sale of U.K. Unit to Santander

1. juuli 2025, 18:41 UTC

Omandamised, ülevõtmised, äriostud

How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com

1. juuli 2025, 18:33 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

1. juuli 2025, 18:33 UTC

Market Talk

Gold Gains as Investors Look Ahead on Budget Bill -- Market Talk

1. juuli 2025, 18:32 UTC

Market Talk

Mexico Manufacturing PMIs Remain Weak in June -- Market Talk

1. juuli 2025, 18:22 UTC

Market Talk

Remittances to Mexico Down in May -- Market Talk

1. juuli 2025, 17:45 UTC

Market Talk

Seasonal Demand Supports Further Oil Gains -- Market Talk

1. juuli 2025, 17:01 UTC

Omandamised, ülevõtmised, äriostud

Danone Completed Acquisition of Majority Stake in Kate Farms

1. juuli 2025, 16:55 UTC

Tulu

10 European Dividend Stocks That Could Beat Their U.S. Counterparts -- Barrons.com

1. juuli 2025, 16:27 UTC

Market Talk

Trade Concerns Ease in Bank of Mexico Survey -- Market Talk

1. juuli 2025, 16:25 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Home Depot's GMS Buy Unlocks New Vertical Adjacent to SRS -- Market Talk

1. juuli 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

1. juuli 2025, 15:48 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Home Depot's Offer for GMS Unlikely to Be Beat -- Market Talk

1. juuli 2025, 15:46 UTC

Market Talk

Global Equities Roundup: Market Talk

1. juuli 2025, 15:46 UTC

Market Talk

Amazon Seen With Improved Logistics Ahead of Longer Prime Day -- Market Talk

1. juuli 2025, 14:54 UTC

Market Talk

Thales Expected to Stick to This Year's Sales Guidance -- Market Talk

1. juuli 2025, 14:49 UTC

Market Talk

Platinum Prices Extend Rally on China Demand, Supply Worries -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Avalo Therapeutics Prognoos

Hinnasiht

By TipRanks

451.1% tõus

12 kuu keskmine prognoos

Keskmine 27.5 USD  451.1%

Kõrge 40 USD

Madal 15 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Avalo Therapeutics 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

2

Osta

0

Hoia

0

Müü

Finantsandmed

$